Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma
Clinical trial NCT03601975 · UNKNOWN
Trial details
- NCT number
- NCT03601975
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2020-07-30
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.